Description: The biological paths that lead to Alzheimer’s disease and other neurodegenerative disorders start many years before clinical symptoms arise. In research settings, diagnostic criteria for these diseases now involve the use of biomarkers that reveal such pathophysiological changes. Visit website to know more.
barcelona (3842) spain (2613) thelancetsummit (1) inflammation and immunity in disorders of the brain and mind (1) the lancet neurology (1) the lancet psychiatry (1)
var xmlfile="resources/includes/tickercontent.txt" //ajax_ticker(xmlfile, divId, divClass, delay, optionalfadeornot) new ajax_ticker(xmlfile, "ajaxticker", "grid-100 sponsors-wrapper margin-small small-font", [3500], "fade")
COPD research and discuss future directions in diagnosis, treatment and therapies at the new international conference ‘COPD: Current Excellence and Future Development’. Specialists in pulmonary diseases will present a highly clinical programme aimed at inspiring and enhancing the care provided to patients with COPD. Register here and join us in Amsterdam, 7-9 May, 2017.
The biological paths that lead to Alzheimer’s disease and other neurodegenerative disorders start many years before clinical symptoms arise. In research settings, diagnostic criteria for these diseases now involve the use of biomarkers that reveal such pathophysiological changes.